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An unprecedented, highly stereoselective rearrangement of guaianolides, bearing a double bond at the
C-6/C-6a position, to tricyclic d-valerolactones is described.
Introduction
The 5,7,5-tricyclic guaianolide framework with a trans-annulated
g-butyrolactone moiety is widely occurring in nature.1 Due to
their broad range of biological activities, being mainly manifested
in the exo-methylene group on the lactone moiety2 as a potent
acceptor for biological nucleophiles, guaianolides have attracted
great interest as synthetic targets, and are also available from
nature in considerable quantities.3
A common structural feature of the guaianolide family is
the presence of a C C double bond between C-6 and C-6a
within the seven membered ring. Typical examples include
Kauniolide4 (1), Ixerin Y (2a) and Ixerin X (2b),5 which were
isolated from the aerial parts of Kaunia arbuscularis and Ixeris
denticulata f. pinnatipartita and Ixeris sonchifolia, respectively
(Fig. 1). During our ongoing studies towards the total synthesis of
biologically active guaianolides,6 we discovered an unprecedented,
stereoselective rearrangement of the title compounds, giving access
to highly functionalized tricyclic d-valerolactones that appear to
be promising as novel scaffolds in organic synthesis as well as for
biological studies.
Fig. 1 Representative examples of the guaianolide family.
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Results and discussion
The trans-annulated g-butyrolactone in the guaianolide frame-
work exhibits considerable ring strain, which causes its facile hy-
drolysis with concurrent ring opening under hydrolytic conditions
(Scheme 1).7
Scheme 1 Hydrolytic lactone opening and lactonisation.
We questioned if the inherent ring strain of the system would
also be sufﬁcient to provoke a reaction by catalysis with Lewis
acids, which have been proven to initiate a great variety of
skeletal transformations8 in organic synthesis, such as pinacol
rearrangements,9 Claisen rearrangements,10 zip-like construction
of annulated rings11 and rearrangements of O-glycoside to
C-glycosides.12
We started our investigation by treating readily available 5 6
with a variety of Lewis acids. While no reaction was observed
with SnCl2, SbCl3 and MnCl2, decomposition of the starting
material occurred upon exposure of 5 to TiCl4. Gratifyingly, a
number of other Lewis acids resulted in a smooth conversion of
5 to give rise to the tricyclic 6,6,6-valerolactone 6 (Scheme 2,
Table 1).
Scheme 2 Lewis acid catalyzed rearrangement of 5 to d-lactone 6.
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Table 1 Screening of different Lewis acids with 5a
Entry Lewis acid Yield (%)b
1 TiCl4 Decomposition
2 SbCl3 No reaction
3 MnCl2 No reaction
4 SnCl2 No reaction
5 ZnBr2 37
6 PCl3 39
7 AlCl3 56
8 FeCl3 66
9 SnCl4 70
10 Bi(OTf)3 80
a Lewis acid (0.25 equiv), 48 h, room temp, DCM. b Isolated yields.
Bi(OTf)3, which has previously been applied successfully in
other rearrangement reactions,13 was found to be especially
suitable to give rise to 6 as a single stereoisomer in 80% yield.
Also, FeCl3 and SnCl4 initiated the rearrangement with good,
albeit with slightly lower yields.
To investigate the scope and limitation of this novel rearrange-
ment and to elucidate the reaction mechanism, several other
compounds containing the guaianolide framework were investi-
gated (Table 2). Along with the 5,7,6-guaianolide analogue 15, the
structures of 6, 10, 14, and 16 were unambiguously established by
X-ray analysis, showing the formation of a 6,6,6- or 6,6,7-tricyclic
skeleton in the most stable, all equatorial arrangement on the ring
junctions.
As a key structural element for the rearrangement of the
guaianolide ring structure, the C C double bond between
C-6 and C-6a14 was identiﬁed (Scheme 4). The corresponding
hydrogenated analogues 17a and 17b gave no conversion, while
the epoxidized analogues 18a and 18b resulted in decomposition
upon treatment with Lewis acids (Fig. 2). Protection of the C-4
hydroxyl group is advantageous in avoiding translactonisation as
a side reaction along the lines reported for the basic hydrolysis of
such compounds (cf. Scheme 1).7
Fig. 2 Guaianolides that do not undergo the title rearrangement.
Remarkably, the highly reactive exo-methylene group on the
lactone ring, representing a key feature in many guaianolide
natural products (cf.Fig. 1), is also tolerated during the rearrange-
ment, even with an unprotected hydroxyl group at C-4. Thus, 9
could be converted in the exo-methylene substituted d-lactone 10
with no observable side reactions such as conjugate addition or
translactonisation (Scheme 3).
Table 2 Lewis acid catalyzed rearrangements of guaianolidesa
Entry Substrate Product Yield (%)b
1 80
2 78
3 55
4 71c
5 75d
6 57
a Bi(OTf)3 (0.25 equiv), 48 h, room temp, DCM. b Isolated yields. c FeCl3
(5.0 equiv, 24 h, 0 ◦C, DCM). d Bi(OTf)3 (0.3 equiv), 72 h.
Scheme 3 Rearrangement of the exo-methylene substituted guaianolide
9 to d-lactone 10.
9 exhibits cytotoxicity against human breast cancer cell lines
(MCF-7, see ESI†) in the typical range of exo-methylene substi-
tuted guaianolides (IC50: 19 mM). However, the cytotoxicity of
the 6,6,6 membered d-valerolactone 10 is about four times lower
2544 | Org. Biomol. Chem., 2011, 9, 2543–2547 This journal is © The Royal Society of Chemistry 2011
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Scheme 4 Proposed reaction mechanism for the conversion of guaiano-
lides to tricyclic d-valerolactones.
(IC50: 72 mM), indicating a less pronounced acceptor quality
against biological nucleophiles in exo-methylene substituted d-
lactones.
Taking all these results into consideration, we propose the
following mechanism encompassing two successive homoallyl-
cyclopropymethyl carbocation rearrangements15 (Scheme 4):
Lewis acid activation causes ring opening of the lactone. The
resulting secondary carbocation I undergoes stereoselective attack
by the homoallylic double bond to form the highly strained but
electronically stabilized tertiary cyclopropyl substituted carboca-
tion II.16 Opening of the cyclopropyl moiety between C-6a and
C-9a to III followed by stereoselective addition of the lactone
oxygen onto C-9a concludes the formation of 6. It should be noted
that the rearrangement occurs with an overall inversion on C-9a
and C-9b. Hence, a concerted mechanism rather than postulated
discrete intermediates I–III would also be in agreement with the
products observed.
Conclusions
In conclusion we discovered a rearrangement, converting the
naturally occurring 5,7,5 tricyclic guaianolide ring system stereos-
electively to a novel tricyclic 6,6,6 d-valerolactone framework. This
reaction can be catalyzed by various Lewis acids, with Bi(OTf)3
being the most favorable.
Experimental
Anhydrous dichloromethane was taken from the MB-SPS solvent
puriﬁcation system. Ethyl acetate and hexanes (40–60 ◦C) were
puriﬁed by distillation before use. All reagents were of p.a. quality.
Reactions were performed in oven dried and in vacuo heated
reaction ﬂasks under a predried inert gas (nitrogen or argon)
atmosphere. 1H and 13C NMR spectra were recorded on a Bruker
Avance 300, and a Bruker Avance 600 Kryo, with a H/C/P/F
QNP gradient probe. The chemical shift d is given in ppm.
Calibration was set on chloroform-d1 as the internal standard
(7.26 ppm for 1H and 77.00 ppm for 13C). The spectra were
evaluated in 1st order and the coupling constants are given in
hertz (Hz).17 Melting points were measured on a Bu¨chi SMP
20 in a silicon oil bath. The melting points are uncorrected.
Infrared-spectra were recorded on a Biorad FT-IR Excalibur FTS
3000. Masspectrometry was performed on Varian MAT 311A,
Finnigan MAT 95, Thermoquest Finnigan TSQ 7000, Nermag
quadrupoles, VG ZAB high-resolution double-focusing and VG
Autospec-Q tandem hybrid with EBEqQ conﬁguration. Optical
rotation was measured on a 241 MC Perkin–Elmer polarimeter
at a wavelength of 589 nm (Na-D) in a 10 cm cell and the [a]D
values are given in 10-1 deg cm2 g-1. X-ray analysis was performed
by the crystallography laboratory of the University of Regensburg
(STOE-IPDS, Stoe & Cie GmbH).
(3aS,4S,9aS,9bS)-6-methyl-2-oxo-2,3,3a,4,5,7,8,9,9a,9b-
decahydrobenzo[de]chromen-4-yl acetate (6)
5 (100 mg, 0.378 mmol, 1 equiv) was dissolved under a nitrogen
atmosphere in anhydrous CH2Cl2 (5 cm3) in a ﬂame dried Schlenk
ﬂask. Bismuth triﬂate (62 mg, 0.095 mmol, 0.25 equiv) was added
in one portion at room temperature and stirred for 48 h. After
completion, the reaction mixture was quenched with aqueous
NaHCO3 solution (1 cm3) and the aqueous phase was extracted
twice with CH2Cl2. The combined organic layers were dried over
Na2SO4, ﬁltrated and the solvent was removed under reduced
pressure. Chromatography on ﬂash silica gel (hexanes : ethyl
acetate 3 : 1) yielded 6 (80 mg, 80%) as a white solid. 6 gave upon
crystallization in a n-pentane–CH2Cl2 mixture at 5 ◦C crystals,
which were suitable for X-ray analysis.
Rf 0.43 (hexanes : ethyl acetate 2 : 1, Mostain); [a]D20 +227.8 (c
1.00 in CHCl3); dH (300 MHz; CDCl3) 1.22–1.40 (1 H, m, 8-H),
1.53 (1 H, ddd, J 3.7, 12.7 and 16.0, 9-H), 1.64 (3 H, s, CH3),
1.69 (1 H, t, J 13.6 Hz, 7-H), 1.83–1.89 (1 H, m, 8-H), 1.96–2.02
(1 H, m, 9b-H), 2.02–2.05 (1 H, m, 3a-H), 2.05 (3 H, s, OAc),
2.07–2.12 (1 H, m, 5-H), 2.11–2.17 (1 H, m, 9-H), 2.30 (1 H, dd,
J 11.8 and 18.3, 3-H), 2.41 (1 H, dd, J 5.6 and 16.7, 5-H), 2.66
(1 H, d, J 14.9, 7-H), 2.90 (1 H, dd, J 5.1 and 18.3, 3-H), 3.91 (1
H, ddd, J 4.3, 10.0 and 11.5 Hz, 9a-H), 4.71 (1 H, dt, J 5.8, 10.2
and 10.4, 4-H); dC (75.5 MHz; CDCl3) 18.87 (+, CH3), 21.02 (+,
COOCH3), 22.73 (-, C-8), 27.06 (-, C-7), 31.73 (-, C-9), 34.51 (-,
C-3), 37.39 (-, C-5), 38.97 (+, C-3a), 45.49 (+, C-9b), 72.10 (+,
C-4), 83.77 (+, C-9a), 125.49 (Cq, C-6), 126.12 (Cq, C-6a), 169.95
(Cq, C-2), 170.70 (Cq, CH3COOC-4); nmax(neat)/cm-1 2970, 2922,
2862, 1723, 1452, 1363, 1240, 1033; m/z (EI) 205.1 (15%) [M+ -
H3CO], 204.1 (100) [M+ - HAc], 162.1 (66), 132.1 (77), 118.1 (74);
m/z (LSIMS): 265.1435 [MH+ C15H21O4 requires 265.1440].
(3aS,4R,9aS,9bS)-6-methyl-2-oxo-2,3,3a,4,5,7,8,9,9a,9b-
decahydrobenzo[de]chromen-4-yl acetate (8)
Rf 0.32 (hexanes : ethyl acetate 2 : 1, Mostain); dH (300 MHz;
CDCl3) 1.20–1.37 (1 H, m, 8-H), 1.50–1.61 (1 H, m, 9-H), 1.63
(3 H, s, CH3), 1.68–1.83 (1 H, m, 7-H), 1.83–1.94 (1 H, m, 8-H),
1.95–2.10 (2 H, m, 9b-H and 2a-H), 2.04 (3 H, s, CH3), 2.10–2.16
(1 H, m, 5-H), 2.16–2.21 (1 H, m, 9-H), 2.40 (1 H, dd, J 3.2 and
18.9, 5-H), 2.46 (1 H, dd, J 11.9 and 18.3, 3-H), 2.62–2.74 (1 H,
m, 7-H), 2.67 (1 H, dd, J 5.4 and 18.3, 3-H), 3.91 (1 H, ddd, J
4.3, 10.0 and 11.5, 9a-H), 4.97 (1 H, dt, J 1.7 and 4.0, 4-H); dC
(75.5MHz; CDCl3) 18.92 (+, CH3), 21.12 (+, COOCH3), 22.84 (-,
C-8), 27.06 (-, C-7), 31.78 (-, C-9), 33.63 (-, C-3), 36.84 (-, C-5),
36.99 (+, C-3a), 40.47 (+, C-9b), 67.85 (+, C-4), 84.08 (+, C-9a),
124.32 (Cq, C-6), 126.08 (Cq, C-6a), 170.25 (Cq, C-2), 170.94 (Cq,
CH3COOC-4).
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 2543–2547 | 2545
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(3aR,4S,9aS,9bS)-4-hydroxy-6-methyl-3-methylidene-
3a,4,5,7,8,9,9a,9b-octahydrobenzo[de]chromen-2(3H)-one (10)
Rf 0.65 (ethyl acetate, Mostain); [a]D20 +333.0 (c 1.00 in CHCl3);
dH (300 MHz; CDCl3) 1.20–1.36 (1 H, m, 8-H), 1.49 (1 H, ddd, J
3.6, 12.7 and 15.9, 9-H), 1.64 (3 H, s, CH3), 1.68 (1 H, bs, OH),
1.78–1.88 (1 H, m, 7-H), 1.90–2.09 (2 H, m, 8-H and 9b-H), 2.11–
2.24 (2 H, m, 9-H and 5-H), 2.33–2.46 (2 H, m, 5-H and 3a-H),
2.65 ( 1H, d, J 14.7, 7-H), 3.96–4.05 (1 H, m, 4-H), 3.91 (1 H,
ddd, J 4.3, 10.0 and 11.5, 9a-H), 6.38 (1 H, m, C-H), 6.49 (1 H,
m, C-H); dC (75.5 MHz; CDCl3) 18.79 (+, CH3), 22.68 (-, C-8),
27.13 (-, C-7), 32.10 (-, C-9), 42.19 (-, C-5), 46.13 (+, C-3a), 46.54
(+, C-9b), 68.03 (+, C-4), 83.46 (+, C-9a), 125.92 (Cq, C-6), 126.09
(Cq, C-6a), 127.46 (-, CH2), 137.40 (Cq, C-3), 165.94 (Cq, C-2);
nmax(neat)/cm-1 3407, 2912, 2864, 2833, 1692, 1612, 1447, 1372,
1275, 1241, 1189, 1147, 1026, 973, 814, 653, 599, 571, 445, 362;
m/z (EI) 234.12537 (M+ C14H18O3 requires 234.1256), 234.1 (M+,
100%), 216.1 (61, M+ - H2O), 201.1 (4, M+ - CH3), 190.1 (76, M+
- CO2), 134.1 (59).
(3aS,8S,9R,9aR,9bS)-8-hydroxy-6,9-dimethyl-3a,4,5,7,8,9,9a,9b-
octahydrobenzo[de]chromen-2(3H)-one (12)
Compound 11 (60 mg, 0.18 mmol, 1 equiv) was dissolved under
a nitrogen atmosphere in anhydrous CH2Cl2 (5 cm3) in a ﬂame
dried Schlenk ﬂask. Anhydrous FeCl3 (29 mg, 0.18 mmol, 1.0
equiv) was added in one portion. After 14 and 18 h reaction
time, more portions of FeCl3 were added (1.0 and 3.0 equiv).
After 24 h hours total reaction time H2O (1 cm3) and CH2Cl2 (10
cm3) were poured into the reaction mixture and the layers were
separated. The aqueous layer was extracted again with CH2Cl2
(1 ¥ 4 cm3 mmol-1). The combined organic layers were dried
(Na2SO4) and concentrated in vacuo. Chromatography on silica
gel (hexanes : ethylacetate 1 : 1) afforded 12 (31 mg, 71%).18
Rf 0.31 (hexanes : ethyl acetate 1 : 1, Mostain); [a]D20 + 98.5 (c
0.540 in CHCl3); dH (300 MHz; CDCl3) 1.20 (3 H, d, J 6.4, 9-
CH3), 1.66 (3 H, s, 6-CH3), 1.68–1.78 (2 H, m), 1.79–1.90 (2 H,
m), 1.91–2.17 (4 H, m), 2.20 (1 H, dd, J 18.3 and 12.2, 7-Hb),
2.73 (1 H, dd, J 18.3 and 5.2, 7-Ha), 2.92 (1 H, J 14.0 and 4.7,
3-Ha), 3.11 (1 H, ddd, J 10.8, 10.4 and 4.6, 8-H), 3.42 (1 H, dd, J
10.4 and 10.4 Hz, 9a-H); dC (75.5 MHz; CDCl3) 13.5 (+, 9-CH3),
19.2 (+, 6-CH3), 27.6 (-), 31.6 (-), 34.9 (+), 36.9 (-), 37.8 (-), 44.7
(+), 44.9 (+), 72.5 (+, 8-C), 86.6 (+, 9a-C), 122.0 (Cq, 6-C), 130.7
(Cq, 6a-C) and 170.9 (Cq, 2-C); nmax(KBr)/cm-1 3408, 3323, 2925,
1732, 1690, 1233, 1055, 799, 645; m/z(EI) 236.1408 (M+ C14H20O3
requires 236.1412).
(3aS,4S,8S,9R,9aR,9bS)-8-hydroxy-6,9-dimethyl-2-oxo-2,3,3a,4,
5,7,8,9,9a,9b-decahydrobenzo[de]chromen-4-yl acetate (14)
In a ﬂame dried Schlenk ﬂask under a nitrogen atmosphere
13 (8 mg, 0.027 mmol, 1 equiv) was dissolved in anhydrous
CH2Cl2 (2.5 cm3) and the solution was cooled down to 0 ◦C.
Anhydrous bismuth triﬂate was added in one portion and the
solution was warmed up to room temperature and stirred for 72 h.
After complete conversion of the starting material, water (1 cm3)
was added and the aqueous phase was extracted with CH2Cl2.
The combined organic layers were dried over Na2SO4, ﬁltrated
and the solvent removed under reduced pressure. Puriﬁcation
by column chromatography on ﬂash silica gel (CH2Cl2 :MeOH
100 : 1) yielded 14 (6 mg, 75%) as a white solid. 14 could be
crystallized from CH2Cl2–hexanes (bp. 60–80 ◦C) at 5 ◦C to give
crystals which were suitable for X-ray analysis.
Rf 0.36 (hexanes : ethyl acetate 1 : 2, phosphomolybdic acid);
mp 179–180 ◦C (decomp., from CH2Cl2–hexanes); [a]D20 +97.4 (c
0.195 in CHCl3); dH (600MHz; CDCl3) 1.23 (3H, d, J 6.9, 9-CH3),
1.64–1.71 (4H,m, 9-H, 6-CH3), 1.72 (1H, d, J 4.8, OH), 1.78–1.89
(1 H, m, 7-Ha), 1.98 (1 H, ddd, J 5.2, 11.1 and 22.8, 3a-H), 2.07 (3
H, s, OAc), 2.03–2.16 (2 H, m, 5-Ha, 9b-H), 2.31 (1 H, dd, J 12.2
and 18.3, 3-Ha), 2.41–2.48 (1 H, m, 5-Hb), 2.91 (1 H, dd, J 5.3 and
18.3, 3-Hb), 2.98 (1H, dd, J 4.7 and 14.1, 7-Hb), 3.15–3.23 (1H,m,
8-H), 3.53 (1H, t, J 10.4, 9a-H), 4.74 (1H, dt, J 5.8 and 10.4, 4-H);
dC (150 MHz; CDCl3) 13.28 (+, 9-CH3), 18.88 (+, 6-CH3), 20.95
(+, O2C-CH3), 34.06 (-, 3-C), 36.56 (-, 7-C), 37.37 (-, 5-C), 38.89
(+, 3a-C), 44.35 (+, 9b-C), 44.81 (+, 9-C), 71.95 (+, 4-C), 72.24
(+, 8-C), 85.66 (+, 9a-C), 122.08 (Cq, C C), 128.34 (Cq, C C),
169.51 (Cq, 2-C), 170.63 (Cq, CH3COOC-4); nmax(neat)/cm-1 3460,
2971, 2839, 1730, 1438, 1377, 1235, 1190, 1070, 1039, 1015, 916;
m/z (LSIMS) 295.1545 (MH+ C16H23O5 requires 295.1552).
(3aS,4S,10aS,10bS)-6-methyl-2-oxo-3,3a,4,5,7,8,9,10,10a,10b-
decahydro-2H-cyclohepta[ij]isochromen-4-yl acetate (16)
Rf 0.40 (hexanes : ethyl acetate 2 : 1, Mostain); [a]D20 +184.0 (c
1.00 in CHCl3); dH (300 MHz; CDCl3) 1.35–1.55 (2 H, m, 8-H,
9-H), 1.63 (3 H, s, CH3), 1.75–2.04 (4 H, m, 10-H, 7-H, 8-H, 9-
H), 2.05 (3 H, s, CH3), 1.07–2.32 (5 H, m, 10b-H, 3a-H, 5-H,
10-H, 3-H), 2.35–2.47 (2 H, m, 5-H, 7-H), 2.83 (1 H, dd, J 3.5
and 17.1, 3-H), 4.15 (1 H, ddd, J 2.5, 10.5 and 10.7, 10a-H),
4.70 (1 H, dt, J 5.8, 9.9 and 10.0, 4-H); dC (75.5 MHz; CDCl3)
19.66 (+, CH3), 21.04 (+, COOCH3), 24.44 (-, C-9), 24.44 (-, C-
8), 29.60 (-, C-7), 33.58 (-, C-10), 36.40 (-, C-3), 37.76 (-, C-5),
39.34 (+, C-3a), 47.95 (+, C-10b), 72.21 (+, C-4), 86.29 (+, C-
10a), 127.43 (Cq, C-6), 127.59 (Cq, C-6a), 170.15 (Cq, C-2), 170.69
(Cq, CH3COOC-4); nmax(neat)/cm-1 2926, 2858, 1725, 1448, 1367,
1326, 1234, 1203, 1134, 1013, 972, 908, 823, 801, 766, 691, 659,
613, 573, 520, 498; m/z (EI) 279.1597 (MH+ C16H23O4 requires
279.1596), 279.1 (MH+, 2%), 218.1 (92) [M+ - HAc], 204.1 (100),
190.1 (60), 172.1 (50), 158.1 (45), 143.1 (49), 119.0 (70), 105.0
(100), 91.0 (42), 42.9 (66).
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